BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1039 related articles for article (PubMed ID: 6219830)

  • 1. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.
    Hubert HB; Feinleib M; McNamara PM; Castelli WP
    Circulation; 1983 May; 67(5):968-77. PubMed ID: 6219830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sudden death in the Framingham Heart Study. Differences in incidence and risk factors by sex and coronary disease status.
    Schatzkin A; Cupples LA; Heeren T; Morelock S; Kannel WB
    Am J Epidemiol; 1984 Dec; 120(6):888-99. PubMed ID: 6239541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia--13-year study.
    Cullen K; Stenhouse NS; Wearne KL; Welborn TA
    J Chronic Dis; 1983; 36(5):371-7. PubMed ID: 6853663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Joint effects of physical activity, body mass index, waist circumference and waist-to-hip ratio with the risk of cardiovascular disease among middle-aged Finnish men and women.
    Hu G; Tuomilehto J; Silventoinen K; Barengo N; Jousilahti P
    Eur Heart J; 2004 Dec; 25(24):2212-9. PubMed ID: 15589638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between cholesterol cholelithiasis and coronary heart disease in Framingham, Massachusetts.
    Bortnichak EA; Freeman DH; Ostfeld AM; Castelli WP; Kannel WB; Feinleib M; McNamara PM
    Am J Epidemiol; 1985 Jan; 121(1):19-30. PubMed ID: 3155483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global cardiovascular mortality risk in the adult Polish population: prospective assessment of the cohorts studied in multicentre national WOBASZ and WOBASZ Senior studies.
    Piotrowski W; Waśkiewicz A; Cicha-Mikołajczyk A
    Kardiol Pol; 2016; 74(3):262-73. PubMed ID: 26365939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relation of antemortem characteristics to cardiovascular findings at necropsy--The Framingham Study.
    Feinleib M; Kannel WB; Tedeschi CG; Landau TK; Garrison RJ
    Atherosclerosis; 1979 Oct; 34(2):145-57. PubMed ID: 518733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk factors in the elderly.
    Castelli WP; Wilson PW; Levy D; Anderson K
    Am J Cardiol; 1989 May; 63(16):12H-19H. PubMed ID: 2523187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification of obesity as a coronary risk factor.
    Kannel WB; Wilson PW; Nam BH; D'Agostino RB
    Am J Cardiol; 2002 Oct; 90(7):697-701. PubMed ID: 12356380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An epidemiological perspective of sudden death. 26-year follow-up in the Framingham Study.
    Kannel WB; McGee DL; Schatzkin A
    Drugs; 1984 Oct; 28 Suppl 1():1-16. PubMed ID: 6499693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life-style correlates of risk factor change in young adults: an eight-year study of coronary heart disease risk factors in the Framingham offspring.
    Hubert HB; Eaker ED; Garrison RJ; Castelli WP
    Am J Epidemiol; 1987 May; 125(5):812-31. PubMed ID: 3565356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body weight, cardiovascular risk factors, and coronary mortality. 15-year follow-up of middle-aged men and women in eastern Finland.
    Jousilahti P; Tuomilehto J; Vartiainen E; Pekkanen J; Puska P
    Circulation; 1996 Apr; 93(7):1372-9. PubMed ID: 8641026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study.
    Stokes J; Kannel WB; Wolf PA; Cupples LA; D'Agostino RB
    Circulation; 1987 Jun; 75(6 Pt 2):V65-73. PubMed ID: 3568338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Framingham Study: historical insight on the impact of cardiovascular risk factors in men versus women.
    Kannel WB
    J Gend Specif Med; 2002; 5(2):27-37. PubMed ID: 11974672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose intolerance, physical signs of peripheral artery disease, and risk of cardiovascular events: the Framingham Study.
    Brand FN; Kannel WB; Evans J; Larson MG; Wolf PA
    Am Heart J; 1998 Nov; 136(5):919-27. PubMed ID: 9812089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure as a risk factor for cardiovascular disease. The Framingham Study--30 years of follow-up.
    Stokes J; Kannel WB; Wolf PA; D'Agostino RB; Cupples LA
    Hypertension; 1989 May; 13(5 Suppl):I13-8. PubMed ID: 2535213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematocrit and the risk of cardiovascular disease--the Framingham study: a 34-year follow-up.
    Gagnon DR; Zhang TJ; Brand FN; Kannel WB
    Am Heart J; 1994 Mar; 127(3):674-82. PubMed ID: 8122618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stratifying the patient at risk from coronary disease: new insights from the Framingham Heart Study.
    Levy D; Wilson PW; Anderson KM; Castelli WP
    Am Heart J; 1990 Mar; 119(3 Pt 2):712-7; discussion 717. PubMed ID: 2137960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipocytokines, C-reactive protein, and cardiovascular disease: a population-based prospective study.
    Seven E; Husemoen LL; Sehested TS; Ibsen H; Wachtell K; Linneberg A; Jeppesen JL
    PLoS One; 2015; 10(6):e0128987. PubMed ID: 26035431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proportional hazards analysis of risk factors for coronary heart disease in individuals aged 65 or older. The Framingham Heart Study.
    Harris T; Cook EF; Kannel WB; Goldman L
    J Am Geriatr Soc; 1988 Nov; 36(11):1023-8. PubMed ID: 2971709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.